Home › Forums › Main Forum › Media & News › HCV New Drugs Blogspot › HCV New Drugs Blogspot
“Pay For Performance” Drug Plans Could Impact Biopharma’s R&D Priorities http://hepatitiscnewdrugs.blogspot.com/2016/05/pay-for-performance-drug-plans-could.html
HCV Next – Chipping Away at Medicaid Restrictions to DAA Coverage http://hepatitiscnewdrugs.blogspot.com/2016/05/hcv-next-chipping-away-at-medicaid.html
Study Shows Nearly 90 Percent of Coloradans Diagnosed With Hepatitis C Go Untreated http://hepatitiscnewdrugs.blogspot.com/2016/05/study-shows-nearly-90-percent-of.html
Curehcvnow@gmail.com http://forums.delphiforums.com/generichcvtx
G 1a F-1 Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil 11/17/15 4 wk lab ALT 17 AST 16 <15 11/18/15 Started Harvoni 12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND 1/14/16 Fin. Tx 7/07/16 UND SVR 24
